Navigation Links
Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
Date:3/11/2008

BRISBANE, Australia, March 11 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) today announced the commencement of its global phase 3 study investigating PI-88 as an adjuvant treatment for primary liver cancer (hepatocellular carcinoma, HCC) following curative resection with the first patient having been randomized onto the study. The study is known globally as PATHWAY (PI-88 in the adjuvant treatment of HCC). The first patient to enter the trial is from Singapore.

Dr. Ronnie Poon, Ph.D., M.D., global lead investigator for PATHWAY, commented, "My colleagues and I are encouraged by the phase 2 data that Progen has generated for PI-88 in this challenging disease, for which there are no approved treatment options. If PATHWAY is successful, PI-88 could change the standard of care for resected liver cancer patients."

PATHWAY, a double-blinded, placebo-controlled study, has been designed to establish the efficacy and safety of PI-88 in the post resection liver cancer setting. The trial will recruit approximately 600 patients at about 65-70 hospitals in more than a dozen countries. Disease-free survival, a measure of the average length of time that patients remain free of tumor recurrence, is the primary endpoint. Upon completion of this trial, the results are expected to form the basis of global registration filings for PI-88.

Justus Homburg, Progen's CEO, said, "Commencement of this trial represents a significant milestone for Progen. We have designed this trial in collaboration with world experts in this field of medicine, and with USA FDA Fast Track and EU EMEA Orphan Drug Status, its initiation underscores our commitment to making this important drug rapidly available to patients who currently have few treatment options available."

Liver cancer is one of the top five causes of cancer deaths in the world, with over half a million new cases per year. Although surgical resection is one of the few treatme
'/>"/>

SOURCE Progen Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
2. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
3. Progen Announces PI-88 Phase 2 Lung Cancer Results
4. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. Inclinix Announces New Patent for Expert System Platform
7. Genzyme Announces Presentation of New Positive Data on Carticel(R)
8. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
9. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
10. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
11. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013   BioCision , a leader in ... in many areas of medical and scientific research, ... the U.S. Patent Office that apply to two ... sample handling to ensure the consistency of test ... procedures. Patent number 8,388,912 covers ...
(Date:6/19/2013)... BURLINGTON, Mass. , June 19, 2013 /PRNewswire/ ... and advisory firms for pharmaceutical and healthcare issues, ... the majority of surveyed U.S. and European rheumatologists ... of the attributes that most influences their prescribing ... U.S. and European rheumatologists, respectively, rank the percentage ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ -- Chindex International, ... American healthcare company providing services in ... Family Healthcare, a network of private hospitals and ... of its Beijing United Family Rehabilitation Hospital ("BJU ... of the United Family Healthcare ("UFH") network. On ...
Breaking Medicine Technology:BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5
... Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or ... marketing and sale of medical devices and homecare medical ... Weibing Yang as and Dr. Genhui Chen directors of ... fills the vacancy resulting from the resignation of Ms. ...
...  Researchers have published the largest single patient population ... patients with retrievable inferior vena cava (IVC) filters—devices ... the lungs. This study, which is important for ... existing guidelines developed by the Society of Interventional ...
Cached Medicine Technology:Dehaier Medical Announces Changes to Board of Directors 2Dehaier Medical Announces Changes to Board of Directors 3IVC Filters: Society of Interventional Radiology Leads in Patient Care, Safety, Research 2IVC Filters: Society of Interventional Radiology Leads in Patient Care, Safety, Research 3IVC Filters: Society of Interventional Radiology Leads in Patient Care, Safety, Research 4
(Date:6/20/2013)... 20, 2013 Millions of Britons are ... medical conditions because they do not brush their teeth ... Elgydium toothpaste. , Seven million Britons do not clean ... between brushes, latest data from the British Dental Health ... polled by the BDHF also admitted that they forgot ...
(Date:6/20/2013)... June 20, 2013 HIPAA One ... guides users through a HIPAA Security Risk Analysis using ... launched today extends the reach of all the HIPAA ... Officers, HIPAA Privacy Officers, security professionals, and members of ... measures, processes, policies and procedures. The new Web ...
(Date:6/19/2013)... 19, 2013 Paleo Burn has finally been ... finally sculpt the body they desire with no fad diets, ... programs and health food products, Ken Smith was bold enough ... consumers an easy, automatic, and permanent solution for weight loss. ... . , After a quick review of Paleo Burn, TotalWellnessCleanse.net ...
(Date:6/19/2013)... June 20, 2013 A man returning from war ... used to be. In his debut book titled RED DANCER JOURNEY, ... who immerses himself back home, looking for the right place and ... Los Angeles, former marine from the Vietnam War, returns to New ... edge off his PTSD. Wings, a wealthy acquaintance from a tiny ...
(Date:6/19/2013)... June 19, 2013 Across the globe ... to no access to the medical advances that benefit ... access to health care and the necessary aid to ... nations. , Outlook with Ben Kingsley ... the conditions in which these people live and highlight ...
Breaking Medicine News(10 mins):Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 3Health News:Modern Compliance Solutions Launches a New Web Site Promoting the Industry-Proven, Web-Based HIPAA One Security Solution 2Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2Health News:Rafael Fragauda’s New Book Underlines Post Traumatic Stress Disorder 2
... mutation could trigger key insulin reaction in some, researchers say ... affects how the body responds when a person smells or ... type 2 diabetes in some people, U.S. researchers report. , ... which some type 2 diabetic people could be vulnerable to ...
... ... live audience of 100 top representatives from government, medical schools, insurance companies, pharmaceutical firms, ... controlling costs. , ... (PRWEB) March 8, 2010 -- The Bloomberg Health & America Briefing , to ...
... ... global EHR solution provider,” says newly appointed President of International Orion Health – Charles ... wins in UK, Spanish and Scandinavian markets. , ... Reading, UK (PRWEB) March 12, 2010 -- To further ...
... , MCHENRY, Ill. , March 11 Medela today announced the launch of an important new resource - www.breastfeedinginsurance.com ... as breastpump rental/purchase or lactation consultants, are covered by insurance. , ... ... ...
... As reported in today,s Wall Street Journal, the more ... on notice that the over-zealous marketing tactics and incentives by manufacturers ... Food and Drug Administration (FDA) for the treatment of atrial fibrillation ... for their patients, heart conditions. , ...
... cuff a warning sign, but exercise regimens can help, experts ... baseball season nears, researchers report that preseason measurements of rotator ... high risk of developing a shoulder injury during play. , ... they are weaker, players are more likely to incur injury ...
Cached Medicine News:Health News:Alert: Bloomberg to Gather Healthcare Experts in Chicago, April 27th 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 3Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 4Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 5Health News:Medela Announces Launch of New Insurance Reimbursement Resource for New and Expectant Mothers 2Health News:Medela Announces Launch of New Insurance Reimbursement Resource for New and Expectant Mothers 3Health News:Medela Announces Launch of New Insurance Reimbursement Resource for New and Expectant Mothers 4Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 2Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 3Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 4Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 5Health News:Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation 6Health News:Pre-Season Test Spots Baseball Pitchers at Risk of Injury 2Health News:Pre-Season Test Spots Baseball Pitchers at Risk of Injury 3
... contact lens has been specifically designed for ... when traditional non-contact slit lamp lenses do ... delivers an outstanding 137° dynamic field of ... as small as 3mm.Evaluated by Harvey Lincoff, ...
... The Digital 1.0x Imaging Lens is optimized for ... glare and reflections during general diagnosis and slit ... of the posterior pole and a sharper image ... 1.0 X Imaging Lens is also ideal for ...
... the "Super 90". Volk's SuperField® has become ... for today's discriminating practitioner. Its ideal .76x ... it perfect as the primary high resolution ... has been specifically designed for increased working ...
... lens started the slit lamp examination revolution! ... design which is outstanding for dynamic fundoscopy. ... the usable viewing field beyond that of ... small pupil capabilities, making it ideal for ...
Medicine Products: